Blueberries Medical Corp. (C:BBM)

Business Focus: Cannabis Product Retailers

Get the company report for the most recent outlook updated daily

Dec 29, 2023 05:00 pm ET

Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement consisting of the sale...

Dec 15, 2023 05:00 pm ET

Blueberries Medical Announces C$2 Million Non-Brokered Private Placement

May 30, 2023 10:35 am ET

Blueberries Medical Reports Q1-2023

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry (together the “Company” or "Blueberries") is thrilled to announce its exceptional financial...

Apr 24, 2023 04:18 pm ET

Blueberries Medical Reports 2022 Financial Results

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the...

Nov 28, 2022 05:00 pm ET

Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement...

Aug 25, 2022 05:50 pm ET

Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together...

Jul 29, 2022 09:19 am ET

Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces that has achieved several CBD and non-psychoactive...

May 30, 2022 05:23 pm ET

Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update

May 03, 2022 10:10 pm ET

Blueberries Medical Reports 2021 Financial Results

Nov 29, 2021 07:30 am ET

Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update

Oct 20, 2021 07:30 am ET

Blueberries Medical Corp Announces that its subsidiary Blueberries SAS has obtained the qualification as Breeding Unit and Exporter of Selected Seeds

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a licensed Latin American producer of medical Cannabis and Cannabis-derived products, today announces that its wholly owned subsidiary Blueberries S.A.S....

Oct 04, 2021 07:30 am ET

Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business t

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS has...

Sep 22, 2021 05:49 pm ET

Blueberries Announces Webcast Instructions for its Annual General and Meeting (“AGM”)

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce webcast link for the Annual General...

Sep 09, 2021 07:30 am ET

Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement...

Aug 30, 2021 07:30 am ET

Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

May 31, 2021 07:12 am ET

Blueberries Medical Reports 2021 Q1 Financial Results and Provides Corporate and Operations Update

Apr 30, 2021 05:30 pm ET

Blueberries Medical Reports 2020 Financial Results

Mar 26, 2021 09:16 am ET

IIROC Trade Resumption - BBM

VANCOUVER, BC, March 26, 2021 /CNW/ - Trading resumes in:

Mar 26, 2021 09:01 am ET

Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company”...

Mar 26, 2021 08:59 am ET

IIROC Trading Halt - BBM

VANCOUVER, BC, March 26, 2021 /CNW/ - The following issues have been halted by IIROC:

Mar 15, 2021 07:30 am ET

Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS will...

Feb 10, 2021 09:04 am ET

Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of José María Forero, the...

Jan 20, 2021 08:30 am ET

Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private...

Dec 04, 2020 07:30 am ET

Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived...

Oct 26, 2020 07:30 am ET

Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products announced today that the Company received approval from the...

Sep 14, 2020 08:35 am ET

Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations

Sep 08, 2020 01:12 pm ET

Live Investor Conference & Webinar: Cannabis Industry Companies Present September 10th

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Sep 08, 2020 07:30 am ET

Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th

Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or "Blueberries"), a Latin American, licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that Camilo Villalba, Co-founder &...

Jul 24, 2020 07:30 am ET

Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the...

Jul 16, 2020 07:30 am ET

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed a non-brokered private...

Jun 08, 2020 07:30 am ET

Blueberries Announces Strategic Partnership with medcann

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that its wholly-owned subsidiary...

Jun 02, 2020 07:30 am ET

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of...

May 05, 2020 07:30 am ET

Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a Joint...

Apr 23, 2020 07:30 am ET

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Ministry of Justice and Law of...

Apr 01, 2020 07:30 am ET

Blueberries Medical Provides Corporate Update

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American producer of medicinal cannabis and cannabis-derived products, is providing the following update on the Company’s recent operating...

Feb 06, 2020 07:45 am ET

Blueberries Medical Commissions First Line at Extraction Facility; Secures Supply Agreements with Contract Growers; Further Strengthens Management Team

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide the following update on the Company’s...

Dec 16, 2019 05:05 pm ET

Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed...

Dec 03, 2019 07:30 am ET

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced harvest of its first...

Oct 31, 2019 05:58 pm ET

Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered...

Sep 27, 2019 11:57 am ET

IIROC Trade Resumption - BBM

VANCOUVER, Sept. 27, 2019 /CNW/ - Trading resumes in:

Sep 27, 2019 11:49 am ET

Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval...

Sep 27, 2019 08:28 am ET

IIROC Trading Halt - BBM

VANCOUVER, Sept. 27, 2019 /CNW/ - The following issues have been halted by IIROC:

Sep 18, 2019 07:30 am ET

Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with The...

Sep 12, 2019 08:28 am ET

Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

Aug 30, 2019 08:00 am ET

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Aug 12, 2019 08:22 am ET

Blueberries Medical Announces $3 Million Non-Brokered Private Placement

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement of up to...

Jul 18, 2019 07:30 am ET

Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update

Jul 04, 2019 07:30 am ET

Blueberries Announces DTC Eligibility of its Common Shares in the United States

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries" or the "Company"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s common...

Jul 02, 2019 07:30 am ET

Blueberries Executes Definitive Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Property in Argentina

Further to its news releases dated March 26 and April 4, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived...

Jun 24, 2019 07:30 am ET

Blueberries Announces Appointment of Chief Financial Officer

Jun 11, 2019 07:30 am ET

Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products and SLANG Worldwide Inc. (CSE: SLNG), (Frankfurt: 84S), (“SLANG”) a...

Jun 05, 2019 07:30 am ET

Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has entered into a...

May 13, 2019 07:45 am ET

Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

Apr 17, 2019 07:45 am ET

Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Eduardo Molinari, a...

Apr 15, 2019 07:45 am ET

Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education P

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries") a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the...

Apr 12, 2019 08:30 am ET

Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

Apr 04, 2019 07:45 am ET

Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American focused licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced the Phase...

Apr 01, 2019 07:45 am ET

Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that its common shares will...

Mar 26, 2019 12:45 pm ET

IIROC Trade Resumption - BBM

VANCOUVER, March 26, 2019 /CNW/ - Trading resumes in:

Mar 26, 2019 12:21 pm ET

Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into...

Mar 25, 2019 03:40 pm ET

IIROC Trading Halt - BBM (all issues)

VANCOUVER, March 25, 2019 /CNW/ - The following issues have been halted by IIROC:

Mar 22, 2019 08:00 am ET

FinancialBuzz.com Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City

NEW YORK, March 22, 2019 /PRNewswire/ -- FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A) live on Wall Street.

Mar 22, 2019 08:00 am ET

FinancialBuzz.com Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City

NEW YORK, March 22, 2019 /CNW/ -- FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A) live on Wall Street.

Mar 20, 2019 07:45 am ET

Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce the appointment of Dr. Patricio...

Mar 19, 2019 08:00 am ET

Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of Fabio Valencia...

Mar 04, 2019 07:30 am ET

Blueberries Medical Lists on Frankfurt Stock Exchange Under Symbol 1OA

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, announces today that its common shares are now listed on...

Feb 25, 2019 07:45 am ET

Blueberries Medical Enters into Agreement with a Leading Colombian Craft Brewer to Pioneer the Development and Commercialization of Cannabis Based Beverages in Latin America

Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries") a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, announces today that it has entered into a letter of intent (the “Agreement”) for...

Feb 20, 2019 09:05 am ET

Three of the Best Ways to Invest in Colombia's Fast-Growing Medical Marijuana Market

HOUSTON, TX / ACCESSWIRE / February 20, 2019 / Colombia is on its way to becoming one of the largest global exporters of medical marijuana.

Feb 20, 2019 07:30 am ET

Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity

Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries") a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products is pleased to announce that it has completed the acquisition of a 37-acre (15...

Feb 14, 2019 08:58 am ET

Top 3 Cannabis Stocks Higher on Colombian Growth Story

HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. In time, growers estimate that the country could capture as much as a fifth of a global market that could be worth $40 billion a year, according to Reuters.

Feb 14, 2019 08:00 am ET

Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV

Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries"), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products, has entered into a letter of intent (the “Letter Agreement”) dated February 13,...

Feb 11, 2019 09:15 am ET

CSE New Listing - Blueberries Medical Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2019) - Blueberries Medical Corp. (CSE: BBM) is one of the latest new listing on the Canadian Securities Exchange, following the reverse take-over of CDN MSolar Corp. Blueberries Medical, through wholly-owned subsidiary Blueberries SAS, is seeking to become a large-scale producer of naturally grown premium quality cannabis in central Colombia.

Feb 06, 2019 09:28 am ET

Three Top Cannabis Stocks to Take Seriously in 2019

HOUSTON, TX / ACCESSWIRE / February 6, 2019 / 2018 was quite an impressive year for IPOs.

Feb 05, 2019 05:28 pm ET

CDN MSolar and Blueberries Cannabis Complete Business Combination to Form Blueberries Medical Corp; Shares to Commence Trading February 6, 2019 Under the Symbol “BBM”

Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries") is pleased to announce the completion of its business combination with Blueberries Cannabis Corp. (the "Private Company"), a leading Colombia-based licenced producer of medicinal...

Ad blocking detected

Blueberries Medical Corp. (C:BBM)

Business Focus: Cannabis Product Retailers